SCHEMBL27101015

SCHEMBL27101015

Cc1nc2c(cc1Cl)n(C)c(=O)c(=O)n2C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPBWR1 P48145 1/20 0.43
MCHR1 Q99705 1/20 0.43
PIK3CA P42336 3/20 0.43
MTOR P42345 1/20 0.43
PRKDC P78527 1/20 0.43
TP53 P04637 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPT P10636 1/20 0.42
THRB P10828 1/20 0.42
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OGFRL1 Q5TC84 1/20 0.41
GPR119 Q8TDV5 5/20 0.40
TNF P01375 1/20 0.39
LITAF Q99732 1/20 0.39
NR3C1 P04150 1/20 0.39
CCR5 P51681 1/20 0.38
HCAR1 Q9BXC0 1/20 0.38
STS P08842 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26879396 0.91 OPRM1 (0.42) NPBWR1MCHR1PIK3CAMTORPRKDC
SCHEMBL24478453 0.90 PIK3CA (0.46) PIK3CAMTORPRKDCTP53KDM4E
SCHEMBL24478472 0.88 PIK3CA (0.43) PIK3CAMTORPRKDCTP53KDM4E
SCHEMBL24478649 0.84 TP53 (0.46) NPBWR1MCHR1PIK3CAMTORPRKDC
SCHEMBL27100941 0.83 HSD11B1 (0.46) NPBWR1MCHR1PIK3CAMTORPRKDC
SCHEMBL29712733 0.83 HSD11B1 (0.46) NPBWR1MCHR1PIK3CAMTORPRKDC
SCHEMBL26676700 0.83 OPRM1 (0.42) NPBWR1MCHR1PIK3CAMTORPRKDC
SCHEMBL29712735 0.83 OPRM1 (0.42) NPBWR1MCHR1PIK3CAMTORPRKDC
SCHEMBL29712748 0.83 PIK3CA (0.47) NPBWR1MCHR1PIK3CAMTORPRKDC
SCHEMBL27100950 0.83 PIK3CA (0.47) NPBWR1MCHR1PIK3CAMTORPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067645-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF LG CHEM, LTD. (KR) 2024-02-29 US disclosed
CN-116615199-A Heterocyclic compounds as diacylglycerol kinase inhibitors and uses thereof 株式会社LG化学 2023-08-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067645-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF DGKA, DGKB, DGKK NPBWR1 2798/4885MCHR1 3767/4885PIK3CA 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.